Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDELALISIB for Prostate cancer: Side Effects & Safety Data

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

There are 5 adverse event reports in the FDA FAERS database where IDELALISIB was used for Prostate cancer.

Most Reported Side Effects for IDELALISIB

Side Effect Reports % Deaths Hosp.
Disease progression 1,204 17.6% 139 130
Death 779 11.4% 779 117
Diarrhoea 752 11.0% 87 510
Off label use 548 8.0% 85 159
Pneumonia 426 6.2% 140 311
Pyrexia 371 5.4% 44 290
Drug ineffective 294 4.3% 62 63
Fatigue 284 4.1% 29 132
Dehydration 242 3.5% 22 212
Dyspnoea 206 3.0% 41 143
Neutropenia 204 3.0% 47 100
Colitis 201 2.9% 41 133
Pneumonitis 199 2.9% 57 133
Asthenia 193 2.8% 22 138
Rash 168 2.5% 27 63

Other Indications for IDELALISIB

Chronic lymphocytic leukaemia (3,537) B-cell lymphoma (1,240) Product used for unknown indication (551) Non-hodgkin's lymphoma (373) Lymphoma (301) Follicular lymphoma (200) Non-hodgkin's lymphoma unspecified histology indolent (164) Waldenstrom's macroglobulinaemia (88) Leukaemia (74) Diffuse large b-cell lymphoma (66)

Other Drugs Used for Prostate cancer

LEUPROLIDE (45,399) ENZALUTAMIDE (25,954) RELUGOLIX (18,752) ABIRATERONE (12,209) APALUTAMIDE (3,286) GOSERELIN (2,080) DEGARELIX (2,035) BICALUTAMIDE (1,832) SIPULEUCEL-T (1,720) DENOSUMAB (1,627)

Related Pages

IDELALISIB Full Profile All Prostate cancer Drugs IDELALISIB Demographics IDELALISIB Timeline